Phase 4 N=200 Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone
Post-operative Pain Control
Primary: Post-operative Average Pain Score — 2.82; 3.58 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=20 Intraarticular Antibiotic in TKA
Antibotics in Cementless Knees
Primary: Concentration of Antibiotics in Cementless Knees Post op — 1702.5; 582.5; 56.1; 1943 micrograms per milliliter
Phase 4 N=154 Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery
Cesarean Section Complications · Wound Breakdown · Wound Infection
Primary: Satisfaction and QoL Questionnaire — 49; 52 Score
Phase 4 N=56 Postpartum HPV Vaccination
HPV-Related Malignancy
Primary: Patient Indication of Willingness to Accept the Vaccine Based on Survey — 56 Participants
Phase 4 N=31 The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
Major Depressive Disorder
Primary: Change in Montgomery and Asberg Depression Rating Scale (MADRS) — 33.28; 16.23 score on a scale — p=<0.001
Phase 4 N=24 A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
Diabetes Mellitus · Type 1 Diabetes
Primary: Number of All Consented Participants — 12; 12 Participants
Phase 4 N=250 Study of the Effectiveness of Administration of Meperidine on the Length of Active Phase of Labor in Women
Labor Pain
Primary: The Duration of Active Phase of Labour — 249; 304 minutes — p=0.029
Phase 4 N=37 Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir Alafenamide
Hiv
Primary: Percentage of Urine Samples Containing TFV in Concentrations Greater Than or Equal to 1000ng/mL From the 7-dose Cohort (1b). — 100; 80; 80; 80 percentage of urine samples
Phase 4 N=140 Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment
Osteoporosis
Primary: Bone Mineral Density (BMD) at Lumbar Spine (L1-L4) — 5.54; 5.39 percent
Phase 4 N=123 CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation
Kidney Transplantation · Kidney Diseases · Kidney Failure
Primary: One Year Survival With a Functioning Graft — 97.6; 95.1 Percent of patients — p=0.467
Phase 4 N=63 Subclinical Cardiovascular Disease in Psoriatic Disease
Cardiovascular Diseases · Myocardial Infarction · Atherosclerotic Cardiovascular Disease
Primary: Mean Fold Change in Brachial Vein Endothelial Inflammatory Transcript — 8.6; 2.8 Fold Change
Phase 4 N=122 Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation
Smoking Cessation · Alcohol Drinking
Primary: Change From Baseline Smoking Abstinence Rates at 12 Weeks — 27; 17 Participants
Phase 4 N=246 DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
Ventricular Tachycardia · Premature Ventricular Contraction · Stroke
Primary: Number of Participants With Transient Ischemic Attack — 6; 22 participants — p=0.001
Phase 4 N=103 Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)
Chemotherapy-induced Nausea and Vomiting
Primary: Percentage of Participants in Cycle 1 Who Experienced One or More Adverse Events (AEs) — 80.0 Percentage of Participants
Phase 4 N=35 Investigation of the Effect of the Female Urinary Microbiome on Incontinence
Overactive Bladder · Incontinence · Nocturia
Primary: Change in the Relative Abundance of Lactobacillus — 0.275 proportion of total microbes